Therex humanized antibody targeting MUC1 regulatory update

ASM received U.S. patent No. 6,204,366 B1 covering antibodies containing specified amino acid sequences that recognize MUC1. MUC1 is highly expressed on most solid tumors, according to ASM. Therex is ...